原文摘要(Abstract) T cell acute lymphoblastic leukemia (T-ALL) is difficult to treat when it relapses after therapy or is chemoresistant; the prognosis of patients with relapsed or refractory T-ALL is generally poor. We report a case series of 17 such patients who received autologous chimeric ...
[2] HAYDU J E,FERRANDO A A. Early T-cell precursor acute lymphoblastic leukaemia[J]. Curr Opin Hematol,2013,20(4):369-373. [3] Arber DA,Orazi A,HasserjianR,et al.The 2016 revision to the World Herlth Org...
The occurrence of T-cell acute lymphoblastic leukemia (T-ALL), on a background of preexisting Philadelphia-negative Myeloproliferative neoplasm is rare. Among the few reported cases where no deep molecular sequencing was performed, it was difficult to ascertain whether these leukemia's occurred de-...
惰性T淋巴母细胞增殖性疾病( indolent T lymphoblastic proliferations,iT-LBP)是一种罕见的在胸腺外淋巴组织或器官中出现T淋巴母细胞非克隆性增殖的疾病[1-2],其临床表现、病理学特点以及流式免疫表型与T淋巴母细胞白血病/淋巴瘤(T-lymphoblastic leukemia/lymphoma, T-ALL/LBL)相似,容易导致误诊,因此MICM多种手段...
2.Zhang X, Yang J, Li J, et al. Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell ...
该文章仅供分享,如涉嫌侵犯您的著作权请联系我们删除,谢谢! 参考资料 1. CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI 2. Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study | Cancer Gene Therapy (nature.com)...
T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive neoplasm of lymphoblasts committed to the T-cell lineage. In 1994, the WHO Classification of Hematologic Malignancies defined T-ALL as precursor T lymphoblastic leukemia/lymphoblastic lymphoma underscoring the unity between the two ent...
T-cell acute lymphoblastic leukemias (T-ALL) are immature lymphoid tumors localizing in the bone marrow, mediastinum, central nervous system, and lymphoid organs. They account for 10–15% of pediatric and about 25% of adult acute lymphoblastic leukemia (ALL) cases. It is a widely heterogeneous...
T-Cell Acute Lymphoblastic Leukemia Market Report published by value market research, it provides a comprehensive market analysis which includes market size, share, value, growth, trends during fore…
Autoimmune Hemolytic Anemia. γRV-GT: Gamma-retroviral-Gene Therapy T-ALL: T-cell acute lymphoblastic leukemia Ia & Ib: Induction therapy a & b; HR1, 2, 3: High-Risk Blocks 1, 2, 3 MRD: Minimal Residual Disease HSCT: Haematopoietic Stem Cell Transplantation DLI: Donor Lymphocyte Infusion...